ADAMED PHARMA SPÓŁKA AKCYJNA
UL. MARIANA ADAMKIEWICZA 6A, 05-152 PIEŃKÓW
TAX ID7311751025
Rate company:
ADAMED PHARMA SPÓŁKA AKCYJNA
TAX ID7311751025
KRS0000116926
Share capital718,430,000.00 zł
address
UL. MARIANA ADAMKIEWICZA 6A, 05-152 PIEŃKÓW
Website
www.adamed.com.pl/pl/Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7311751025 
REGON
472293752
KRS
0000116926
Legal form
joint stock company
Register Address
UL. MARIANA ADAMKIEWICZA 6A, 05-152 PIEŃKÓW
Date of registration in KRS
2002-06-07
Date of commencement of economic activity
2002-06-07
Act signature
WA.XIV NS-REJ.KRS/25834/25/761
Website
WWW.ADAMED.COM.PL/PL/
Pkd codes
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
20.4 - Manufacture of cleaning, washing, and cleaning products
21.1 - Manufacture of basic pharmaceutical products
47.73 - Retail sale of pharmaceutical products
70.1 - Head office activities
70.2 - Business and management consultancy activities
71.2 - Technical testing and analysis
72.1 - Scientific research and development in natural and technical sciences
73.1 - Advertising
77.1 - Rental and leasing of motor vehicles
Payer VAT status
Active
Vat list bank account(s)
PL97 1240 6292 1111 0011 2549 4800 
PL98 1240 6292 1111 0011 2068 1739 PL82 1240 6292 1111 0011 2068 8914 PL17 1240 6292 1111 0011 2068 1742 PL10 1240 6292 1111 0011 2067 8667 
PL72 1160 2202 0000 0005 2626 1659 PL53 1240 6292 1111 0011 1012 7979 PL63 1240 6292 1111 0010 8893 6306 PL52 1240 6292 1111 0010 9181 5076 PL62 1240 6292 1111 0011 0395 1730 PL04 1240 6292 1111 0010 4698 1667 PL05 1240 6292 1111 0010 7627 3806 PL09 1240 6074 1787 0010 3641 4386 
PL09 1600 1143 0003 0602 3319 7001 
PL12 1140 1010 0000 5590 0900 1025 
PL15 1130 1163 0014 7151 4920 0002 PL21 1160 2202 0000 0002 2514 8484 
PL24 1030 1508 0000 0008 1735 5005 PL24 1240 6292 1213 0010 7281 0023 PL24 1600 1143 0003 0602 3319 7022 PL24 1600 1462 0008 8092 3319 7021 PL29 1240 6074 1797 0010 3641 3914 PL34 1240 6292 1111 0010 9958 4130 PL37 1240 6074 1789 0010 3641 4461 PL39 1140 1010 0000 3422 4000 1001 PL39 1140 1010 0000 5590 0900 1024 PL40 1600 1143 0003 0602 3319 7025 PL42 1130 1163 0014 7151 4920 0001 PL42 1240 6074 1978 0010 3640 7346 PL48 1240 3044 1111 0010 4274 1300 PL51 1140 1010 0000 5590 0900 1002 PL51 1600 1143 0003 0602 3319 7021 PL52 1240 6074 1111 0010 2328 0923 
PL60 1090 2835 0000 0001 3018 9834 PL60 1140 1010 0000 3422 4000 1011 PL60 1240 6292 1111 0010 9407 3189 PL65 1240 3480 1111 0000 4268 9843 PL67 1600 1143 0003 0602 3319 7024 PL69 1240 3451 1111 0010 3847 2229 PL70 1240 6292 1111 0010 6385 9837 PL78 1140 1010 0000 5590 0900 1001 PL83 1600 1143 0003 0602 3319 7027 PL84 1240 3044 1111 0010 3628 8600 PL85 1130 1163 0014 7151 4920 0003 PL94 1600 1143 0003 0602 3319 7023 Show more bank accounts from VAT list (42)
EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 2258,4 | 2525,5 | 2727,1 | 8 |
Gross profit (loss) | 201,6 | 253,5 | 297,7 | 17,5 |
Net profit (loss) | 152 | 210,9 | 240 | 13,8 |
Cash | 445 | 407,9 | 495,1 | 21,4 |
Liabilities and provisions for liabilities | 466,4 | 522,4 | 492,4 | -5,8 |
Net income from sale | 1291,2 | 1471,3 | 1723,3 | 17,1 |
Short time liabilities | 284,2 | 339,6 | 271 | -20,2 |
Equity capital | 1792 | 2003 | 2234,7 | 11,6 |
Working assets | 1202,6 | 1288,7 | 1352,9 | 5 |
Operating profit (EBIT) | 229,9 | 251,2 | 323,3 | 28,7 |
% | % | % | p.p. | |
Equity capital to total assets | 79,3 | 79,3 | 81,9 | 2,6 |
Gross profit margin | 15,6 | 17,2 | 17,3 | 0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 80 | 84 | 57 | -27 |
Current financial liquidity indicator | 3.8949153423309326 | 3.4847559928894043 | 4.356608867645264 | 0,9 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xades01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Consolidated annual financial statements
Download xades01-01-2023 - 31-12-2023
Consolidated annual financial statements
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the consolidated annual financial statements of the capital group
Download pdf01-01-2023 - 31-12-2023
A report on the activities of the parent company and a report on the activities of the capital group
Download pdf01-01-2023 - 31-12-2023
A resolution or a decision approving the consolidated annual financial statements
Download pdf01-01-2023 - 31-12-2023
Uchwała o podziale zysku bądź pokryciu straty;
Download pdfShow more (9)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
CYTOGEN-POLSKA
ŁÓDŹ
Merkury S.A.
Białystok
DKR Medical sp. z o.o.
Poznań
Marek Mazurkiewicz
Zabrze
Interton.pl sp. z o.o.
Kraków
Katarzyna Zielińska-Mika APTEKARZ
Nakło nad Notecią
Med Digital sp. z o.o.
Warszawa